RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR OF PARACETAMOL & ZALTOPROFEN IN PHARMACEUTICAL DOSAGE FORM Authors: Bhosale V M , SONVANE S. M*., BIRAJDAR M.J., SATPUTE K.L., SHETKAR B.M., GADGUL A.B. AND SHIVNECHARI P.M
ABSTRACT
In this investigation, we tried developing a precise and reliable stability assay method for
paracetamol and Zaltoprofen simultaneous measurement in API and pharmaceutical dosage
forms using RP-HPLC. To obtain adequate separation, an Agilent TC C18 column was used,
and a PDA detector was used for the study. 0.2% Triethylamine: Acetonitrile (50:50 v/v)
mixture, flowing at 1 milliliter per minute. Using a diode array detector, the eluent at 243 nm
was observed. The retention time of paracetamol is 3.0 while that of Zaltoprofen is 5.2. With a
correlation coefficient better than 0.99, the measured signal was demonstrated to be precise,
accurate, and linear over the concentration range evaluated. The current method's accuracy was
assessed at 80%, 100%, and 120%. Recovery rates for both paracetamol and Zaltoprofen is
100.2% and 98.93%, respectively, the HPL.C. Method for determining the assay of
Paracetamol and Zaltoprofen is correct. There was determined to be a precision RSD within
range. The RP-HPLC approach may be successfully employed for the simultaneous
measurement of Paracetamol and Zaltoprofen in their formulation, as demonstrated by the
results from the preceding data.
Keywords: RP-HPLC, Zaltoprofen, Paracetamol, PDA detectors Publication date: 01/11/2024 https://ijbpas.com/pdf/2024/November/MS_IJBPAS_2024_9634.pdfDownload PDFhttps://doi.org/10.31032/IJBPAS/2024/13.11.9634